Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EOG vs MRNA✓SelectedUSD · MRNAEOG vs MRNA performance historyLatest closeAs of-0.60%11/20
Stock and ETF performance explorer

EOG vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+117.5%
MRNA return
-27.3%
Excess return
+144.7%
Maximum drawdown
-33.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.6%-2.2%+1.6%-0.6%
7D-6.1%-12.7%+6.6%-6.1%
30D-5.9%-20.7%+14.8%-5.8%
3M-1.7%+46.3%-48.0%-2.1%
6M+6.4%+305.2%-298.8%+3.3%
YTD+46.0%+561.2%-515.2%+38.6%
1Y+44.6%+772.1%-727.5%+35.6%
3Y+32.0%+147.0%-114.9%+26.7%
All+117.5%-27.3%+144.7%+100.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling